# Clobetasol

## Clobetasol ointment 0.05% 25gm

##### 

| TAH Drug Code      | [ECLOO2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ECLOO2)                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Psoriasis; recalcitrant eczema; lichen planus; discoid lupus erythematosus & other skin conditions which do not respond satisfactorily to less active steroids.                                                                                                                                                                                                                                                                  |
| Dosing             | Apply sparingly to the affected area once daily or bid.                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to clobetasol or any ingredient in the preparation. Primary scalp infection. Apply the smallest amount that will cover affected area. For topical use only; avoid contact with eyes and mucous membranes. Do not apply to face, scalp, axilla, groin, or intertriginous areas. Do not use if there is atrophy at the treatment site. Minimize contact to nonaffected areas of the body. Wash hands after use.   |
| Adverse Effects    | Common Dermatologic: Asteatotic eczema (2% ), Atrophic condition of skin (Up to 4.2% ), Burning sensation, Discomfort, Skin (1.3% ), Dry skin (1% to 2% ), Pruritus (0.5% to 3% ) Respiratory: Nasopharyngitis (5% ), Upper respiratory infection (8% ) Serious Endocrine metabolic: Hypothalamic-pituitary-adrenal axis dysfunction (Adult, 15% to 30.8% ; pediatric, 42% to 47% ) Neurologic: Intracranial hypertension, acute |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                    |

## Vimax foaming solution 25mL

##### 

| TAH Drug Code      | [EVIM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EVIM)                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Psoriasis, recalcitrant eczema.                                                                                                                                                                                                                                                                             |
| Dosing             | Plaque psoriasis Apply sparingly to the affected area once or BID. Treatment should be stopped if the condition improves after treatment for more than four weeks.                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                               |
| Contraindications  | Bacterial infections (eg. impetigo, furuncle, boils, cellulitis), candidiasis, dermatophytes infection, herpes simplex or herpes zoster infections. Avoid application near the eyes. Rosacea, perioral dermatitis & acne.                                                                                   |
| Adverse Effects    | Local skin reactions: burning sensation, itch, rash, folliculitis, hypertrichosis, hypopigmentation, perioral dermatitis, allergic dermatitis, wrinkles, miliaria. HPA axis suppression, Cushing syndrome, hyperglycemia, DM. Cataract & glaucoma, skin atrophy, telangiectasia & purpura on prolonged use. |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                               |

